SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending due to robust earnings that significantly surpassed expectations, coupled with the revelation of advanced negotiations for substantial new data center capacity, reinforcing its position in the booming AI infrastructure sector. Community discussion is heavily focused on bullish sentiment, fueled by insider confidence from a CEO equity package tied to ambitious stock price milestones and recent analyst upgrades, with many anticipating further upside and a potential short squeeze.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending following high-profile political praise for its domestic chip manufacturing and strategic government investment. The community is actively discussing the potential for major defense contracts or partnerships with tech giants, fueling expectations for a significant breakout and a short squeeze. This renewed focus on Intel's foundry business and its role in national semiconductor independence is driving bullish sentiment amid its turnaround efforts.

Rich Sparkle Holdings Ltd. engages in the provision of financial printing and corporate services. The firm offers typesetting, proofreading, translation, design, and printing of listing documents, financial reports, fund documents, circulars, and announcements. It also delivers advisory services, such as conducting internal control assessment and environmental, social and governance performance evaluation, and other services including provision of co-working space. The company was founded in 2016 and is headquartered in Hong Kong.

Rich Sparkle Holdings Ltd.

Rich Sparkle Holdings Limited

ANPA is witnessing intense investor interest following news of a $39 million private placement and the recent expiration of its IPO lock-up period. The community is actively debating if this marks a sustained, parabolic "Hong Kong play" surge, with some anticipating significant price levels, while others caution it resembles a volatile "pump and dump" given its rapid ascent and the underlying offering price disparity.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

ProShares Ultra Bloomberg Natural Gas (BOIL) is experiencing extreme selling pressure amid collapsing natural gas prices, primarily driven by extended warm weather forecasts. The community is largely in distress over significant losses and the product's notorious "widow maker" reputation, while some are attempting to scalp or position for a potential short-term bounce.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is trending due to market anticipation of significant price hikes for its high-capacity NAND memory, spurred by immense demand from AI infrastructure. This has ignited a parabolic rally and widespread speculative buying, with the community actively discussing both extreme bullish sentiment and a surge in shorting activity amidst calls of "Tulip Mania".

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo Inc. is actively trending following its landmark agreement with Meta Platforms to develop a 1.2GW nuclear power campus for AI data centers, signaling a significant move towards advanced nuclear solutions for burgeoning energy demands. The community is buzzing with discussions about a potential short squeeze and high price targets, though some observers question the long timeline for revenue and the stock's current valuation. Amidst this, anticipated DOE plutonium awards and broader pro-nuclear policy further fuel speculative interest in Oklo's role in the evolving energy landscape.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following crucial FDA feedback that significantly de-risks the path to approval for its lead drug, sonelokimab. The community is buzzing with renewed optimism for a potential major pharma buyout, citing the drug's 'best-in-class' status for inflammatory skin diseases and anticipating a substantial short squeeze as analysts raise price targets.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending following its recent inclusion in the S&P MidCap 400, expected to drive increased institutional ownership and market attention. The community is divided, with bulls highlighting the company's strong balance sheet, pivot to Agentic AI orchestration, and strategic partnerships as catalysts for a potential breakout. However, skeptics express frustration over perceived price manipulation and the stock's struggle to consistently hold gains, despite its fundamental strengths in the evolving AI landscape.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is a focal point of market discussion, driven by intense speculation and regulatory scrutiny surrounding its proposed acquisition of Warner Bros. Discovery assets. Community sentiment is sharply split, with some viewing the current price as a compelling dip to buy before its anticipated earnings, while others remain wary of the deal's potential financial and competitive burden.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Quince Therapeutics, Inc. (NASDAQ:QNCX) Sees Large Growth in Short Interest

Quince Therapeutics, Inc. (NASDAQ:QNCX - Get Free Report) was the recipient of a significant growth in short interest in December. As of December 15th, there was short interest totaling 2,064,545...

Quince Therapeutics Announces Last Patient Last Visit in Phase 3 NEAT Clinical Trial in Patients with Ataxia-Telangiectasia

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patients own biology for the treatment of rare diseases, today announced that the...

Quince Therapeutics Announces Publication of Use of eDSP in Early-Stage Clinical Studies in Pulmonary and Inflammatory Bowel Disorders

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patients own biology for the treatment of rare diseases, announced the publication...

Monday Sector Laggards: Biotechnology, Electronic Equipment & Products

In trading on Monday, biotechnology shares were relative laggards, down on the day by about 3%. Helping drag down the group were shares of Quince Therapeutics, down about 16.2% and shares of Kalaris...

169,554 Shares in Quince Therapeutics, Inc. $QNCX Bought by Rockefeller Capital Management L.P.

Rockefeller Capital Management L.P. purchased a new stake in Quince Therapeutics, Inc. (NASDAQ:QNCX - Free Report) in the second quarter, according to its most recent Form 13F filing with the...

Quince Therapeutics to Participate at Investor Events in December 2025

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patients own biology for the treatment of rare diseases, today announced that senior...

Brookline Capital Management Predicts QNCX FY2028 Earnings

Quince Therapeutics, Inc. (NASDAQ:QNCX - Free Report) - Brookline Capital Management cut their FY2028 earnings estimates for shares of Quince Therapeutics in a report released on Thursday, November...

D. Boral Capital Reiterates "Buy" Rating for Quince Therapeutics (NASDAQ:QNCX)

D. Boral Capital reissued a "buy" rating and issued a $4.00 price target on shares of Quince Therapeutics in a research note on Thursday...

Quince Therapeutics (NASDAQ:QNCX) Announces Quarterly Earnings Results

Quince Therapeutics (NASDAQ:QNCX - Get Free Report) released its quarterly earnings data on Wednesday. The company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus...

Quince Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patients own biology for the treatment of rare diseases, today provided an update on...

Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in the unlocking the power of a patient’s biology for the treatment of rare diseases. Its product includes EryDex, developed using their proprietary Autologous Intracellular Drug Encapsulation (AIDE) technology platform, which is a novel device combination that uses an automated process designed to encapsulate a drug into the patient’s own red blood cells. The company was founded by Casey Crawford Lynch, Stephen Dominy, and Kristen Gafric on June 20, 2012 and is headquartered in South San Francisco, CA.

Quince Therapeutics Inc

Yes — Rates Move Meaningfully Lower

Short-Term Dip, No Lasting Impact

No — Mostly Political Noise

Other – Comment Below

President Trump says he’s directing $200 billion into mortgage bond purchases to bring down rates and improve housing affordability. With questions around execution, authority, and real market impact, do you think this move will actually lower mortgage rates in 2026?

Will Trump’s Mortgage Bond Plan Actually Lower Rates in 2026?

Current Price	$2.69
Prev Close	$2.68
Open	$2.75
Dividend Yield	0.00%
50-Day Moving Average	$2.81
Beta	0.19
Avg. Volume	864,273.45
PE Ratio	-2.20

52-Week High	$4.55
52-Week Low	$0.7203
Market Capitalization	$149.23M
EPS (Annual)	-$1.31
Price to Book	137.93
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

QNCX
Quince Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest QNCX News

QNCXQuince Therapeutics Inc